Related Experiment Video

Updated: Aug 11, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

Anti-CD38 autoimmunity in children with newly diagnosed type 1 diabetes mellitus

C Pupilli1, A Antonelli, L Iughetti

  • 1Endocrinology Unit, Azienda Ospedaliera Careggi and University of Florence, Italy.

Journal of Pediatric Endocrinology & Metabolism : JPEM
|February 8, 2006
PubMed

Insights

Autoimmunity against CD38 is linked to new cases of type 1 diabetes mellitus (DM1) in children. This CD38 autoimmunity increases and persists over time in children with DM1.

Area of Science:

  • Immunology
  • Endocrinology
  • Pediatrics

Background:

  • Type 1 diabetes mellitus (DM1) is an autoimmune disease.
  • CD38 is a protein expressed in human islets, a potential target in autoimmune responses.
  • Understanding autoimmune targets in DM1 is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the presence and significance of anti-CD38 autoantibodies in children with newly-diagnosed type 1 diabetes mellitus.
  • To determine if anti-CD38 autoimmunity is associated with the development or progression of DM1 in pediatric patients.

Main Methods:

  • Serum samples from 270 children with newly-diagnosed DM1 and 179 healthy controls were analyzed for anti-CD38 autoantibodies using Western blot.
  • Follow-up samples were collected from 126 diabetic children after 15 months.
  • Statistical analyses, including chi-squared tests and correlation analysis, were performed.

Main Results:

  • Anti-CD38 autoantibodies were detected in 4.4% of children with DM1, significantly higher than in controls (0.6%, p <0.016).
  • No phenotypic differences were observed between anti-CD38 positive and negative patients.
  • A positive correlation (r = 0.46, p <0.0001) was found between antibody titers at diagnosis and follow-up, with new cases of autoimmunity emerging over time.

Conclusions:

  • An autoimmune reaction against CD38 is associated with newly-diagnosed type 1 diabetes mellitus in children.
  • CD38 autoimmunity appears to increase and persist in children with DM1 over time.
  • These findings suggest CD38 as a potential target in the autoimmune process of pediatric DM1.
Abstract

More Related Videos

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases06:50

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

Published on: May 29, 2020

Electrochemiluminescence Assays for Human Islet Autoantibodies09:15

Electrochemiluminescence Assays for Human Islet Autoantibodies

Published on: March 23, 2018

Related Concept Videos

Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...